eCyte, Inc.
PrivateLast Round
Series A
Extension
Jan 19, 2026
Total Funding Raised
$27.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
eCyte, Inc. operates in Healthcare & Life Sciences and is based in Sunnyvale, California. Its latest recorded funding round was a Series A Extension round in January 2026.
eCyte, Inc. is a biotechnology company that develops and commercializes scientific instruments for phenotype-based single-cell profiling and sorting.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eCyte, Inc. Comparables
Compare eCyte, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hooke Instruments Ltd. | 84% | |
| Deepcell | 77% | |
| ThinkCyte | 76% |
For institutional investors. Book with your work email.
eCyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 19, 2026 | ||||
| Series A Extension | Apr 1, 2024 | ||||
| Series A | Dec 12, 2023 |
For institutional investors. Book with your work email.
eCyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingdao Zhongke Yucheng Investment Management Co., Ltd. | Series A Extension |
| Shandong Caijin Investment Group | Series A Extension |
| Beiyang Haitang Venture Capital Fund | Series A |
| Hengxu Capital | Series A |
| 浙江浙商资本管理有限公司 | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
$14M round with participation from Qingdao Zhongke Yucheng and Shandong Caijin.
- Apr 1, 2024
Kweichow Moutai Co Ltd participated in the round.
For institutional investors. Book with your work email.
eCyte, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about eCyte, Inc.'s valuation, stock price, and market status.
Is eCyte, Inc. a public or private company?
eCyte, Inc. is a private company.
What is the current stock price of eCyte, Inc.?
eCyte, Inc. is a private company, so its shares have no public market price. Caplight tracks eCyte, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is eCyte, Inc. worth (valuation)?
Valuation information for eCyte, Inc. is not publicly available.
Can I buy eCyte, Inc. stock?
eCyte, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was eCyte, Inc.'s last funding round?
eCyte, Inc.'s most recent funding round was Series A Extension on January 19, 2026.
Who are the main investors in eCyte, Inc.?
Key investors in eCyte, Inc. include Hengxu Capital.
Will eCyte, Inc. IPO soon?
No public IPO plans have been announced for eCyte, Inc..
How can I track eCyte, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in eCyte, Inc.'s shares on secondary markets.